March 15th 2023
A model to estimate the optimal number of oocytes to try to fertilize during assisted reproductive technology (ART) treatment predicted that 43.4% of oocyte retrievals were day 3 transfers; hence, exposing all oocytes to sperm is recommended.
March 8th 2023
Poll: Will new technology bring a resurgence in enthusiasm for single port surgery?January 5th 2022
Much innovation has taken place in the field of minimally invasive gynecologic surgery in the last decade. Enthusiasm for single-port surgery has waned over the past decade, due to factors like Reimbursement issues and technical demand led to a decrease in enthusiasm, but robotics companies continue to develop new solutions.
Robotic surgery: A viable option for pectopexyJanuary 5th 2022
While sacrocolpopexy has been the gold standard for the anatomical correction of pelvic organ prolapse for more than three decades, it is a technically challenging procedure that results in dividing the pelvis by mesh material and often requires extensive bowel manipulation.
Cytology dual-stain biomarker for detecting HPV-driven cervical precancerDecember 27th 2021
A prospective observational screening study has concluded a cytology dual-stain (DS) biomarker effectively triages women who test positive for primary human papillomavirus (HPV) and are at higher risk of developing cervical cancer, irrespective of the HPV genotype.
Study confirms adding palbociclib to endocrine therapy may not improve outcomes in early breast cancerDecember 10th 2021
The addition of palbociclib to endocrine therapy was not associated with preventing disease recurrence in patients with hormone receptor (HR)–positive, human epidermal growth factor receptor 2 (HER2)–negative early breast cancer, according to final results of the phase 3 PALLAS trial.
Type 2 diabetes risk not associated with gender-affirming hormone therapy, study showsDecember 9th 2021
A recent analysis suggests transfeminine individuals were at a 40% greater risk of developing diabetes than their cisgender counterparts, but this increase in risk was not attributable to gender-affirming hormone therapy.
Current choices in cervical cancer screeningDecember 6th 2021
It is essential to expand access to all available, effective cervical cancer screening options for the most vulnerable populations. The targeted use of any particular screening modality in higher-risk populations is not supported by evidence-based guidelines; any effective screening is the priority.
The superior method for pelvic organ prolapse repair: Mesh or native tissue repair?November 17th 2021
At AAGL’s 50th Global Congress on MIGS, Peter L. Rosenblatt, MD, and Cheryl B. Iglesia, MD, FACOG, debated the use of native tissue repair and transvaginal mesh in pelvic reconstructive surgery.
Radiofrequency ablation for uterine fibroidsNovember 16th 2021
In a panel discussion at AAGL’s 50th Global Congress on MIGS, in Austin, Texas, Kimberly Kho, MD, MPH, along with Jessica Shepherd, MD, MBA, FACOG, and Craig Sobolewski, MD, discussed utilizing radiofrequency ablation for treatment of uterine fibroids.
The need for office hysteroscopies in your practiceNovember 16th 2021
“My hysteroscope is my stethoscope. I use it in every opportunity when the story doesn’t match,” Linda D. Bradley, MD, said during her presentation at AAGL’s 50th Global Congress on MIGS, “Office Hysteroscopy: Seeing is Believing. A Manifesto for Change.”
Building a framework for a multidisciplinary approach to chronic pelvic pain therapyNovember 15th 2021
“If you want to provide comprehensive care, it is truly impossible as 1 person,” began Jean Uy-Kroh, MD, FACOG, director, Chronic Pelvic Pain Program at the Cleveland Clinic in Cleveland, Ohio, at AAGL’s 50th Global Congress on MIGS in Austin, Texas.
Robotic-assisted surgery for gynecologic proceduresNovember 9th 2021
“Today, many of these cases are done as open surgery, including approximately 60% of all hysterectomies performed globally, despite the clear benefits of minimally invasive surgery, which includes fewer complications, a shorter hospital stay, and a faster return to normal activities,” Peron told Contemporary OB/GYN®.
vNOTES: where does it fit in the gynecologic surgery armamentarium?November 8th 2021
The reality is that traditional laparoscopic surgery provides excellent outcomes, great surgical exposure, and the flexibility to tackle almost any clinical situation. As such it is a high bar to overcome—vNOTES is essentially single port vaginal surgery.
MIGS surgeons discuss novel vNOTES technologyNovember 5th 2021
Contemporary OB/GYN® held a panel discussion in September with 4 renowned minimally invasive gynecologic surgeons (MIGS) who discussed vaginal natural orifice transluminal endoscopic surgery (vNOTES).
Menstrual cycle length changes linked to increased risk of atherosclerosisOctober 19th 2021
In an analysis of SWAN data, investigators found changes in menstrual cycle length within the 5 years preceding a woman's final menstrual period was associated with changes in carotid intima-media thickness and brachial-ankle pulse wave velocity.
The stigma around antibiotics for recurrent UTIsOctober 15th 2021
Recurrent urinary tract infections (UTIs) place a large burden on women as they struggle to find the right remedies for this problem. According to guidelines, there is only 1 temporary cure for this condition and that is antibiotics. As more antibiotics are taken by this susceptible population, however, the bacteria can adapt and make recurrent UTI treatment in the future much more difficult.
Priority review granted for cemiplimab for advanced cervical cancerOctober 6th 2021
The FDA has granted priority review to a supplemental biologics license application for the use of cemiplimab-rwlc in the treatment of patients with recurrent or metastatic cervical cancer whose disease progressed on, or after, chemotherapy.
Novel vaccine for recurrent UTIsSeptember 21st 2021
Women who suffer from recurrent urinary tract infections (rUTIs) are typically treated with antibiotics. These treatment regimens, however, are associated with high rates of morbidity as the world faces rising antibiotic resistance.